Summary

Biopreservation Trends and Forecast

The future of the global biopreservation market looks promising with opportunities in the hospital, biobank, and gene bank markets. The global biopreservation market is expected to reach an estimated $17 billion by 2031 with a CAGR of 28.1% from 2025 to 2031. The major drivers for this market are increasing R&D investments, advancements in biobanking, the growing trend of conserving cord blood stem cells of newborns, rising investments in regenerative medicine research, and increasing demand for personalized medicine.

• Lucintel forecasts that, Within the type category, equipment is expected to witness higher growth over the forecast period due to increasing demand for bio-banks, extensive usage in DNA, plasma, stem cell, and tissue research, widespread adoption, high-cost efficiency, and low maintenance.
• Within the end use industry category, biobanks will remain the largest segment due to growing awareness of biopreservation among researchers, an increasing number of sperm and egg banks, the adoption of assisted reproductive technology, a collaboration of biopharmaceutical companies with national bio-banks, and tissue preservation centers at hospitals.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to consistent drug developments and advanced therapies in the field of biomedical research, rise in patient base requiring high-end treatment for chronic diseases, and high demand for biopreservation products and services.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Biopreservation Market

The biopreservation market is witnessing several transformative trends that reshape the field. These trends reflect advancements in technology, evolving market demands, and the growing importance of maintaining the integrity of biological materials. Understanding these trends helps stakeholders anticipate future developments and adapt their strategies accordingly.

• Increased Use of Artificial Intelligence (AI): AI is revolutionizing biopreservation by enhancing the monitoring and management of storage conditions. AI-driven systems analyze real-time data to optimize preservation protocols, predict potential issues, and automate responses. This technology improves the reliability and efficiency of biopreservation processes, reducing human error and ensuring better outcomes for biological samples. AI’s predictive capabilities also facilitate proactive maintenance of preservation equipment, minimizing risks and extending sample viability.
• Sustainable Biopreservation Solutions: There is a growing emphasis on sustainable biopreservation methods, driven by environmental concerns and regulatory pressures. Innovations include the development of eco-friendly cryoprotectants and energy-efficient storage systems. These solutions aim to reduce the environmental footprint of biopreservation processes while maintaining high standards of sample integrity. Sustainable practices are becoming essential for companies looking to enhance their corporate responsibility and comply with emerging environmental regulations.
• Advances in Cryopreservation Technologies: Cryopreservation continues to evolve, with new technologies improving sample storage and recovery. Recent advancements include enhanced cryoprotectants that reduce ice crystal formation and novel cooling techniques that improve cell viability. These innovations address previous limitations in cryopreservation, such as damage during thawing and long-term storage challenges, thereby supporting the growing demand for high-quality biological samples in research and clinical applications.
• Expansion of Biobanking Facilities: The expansion of biobanking is a significant trend, driven by the increasing demand for biological samples in research and personalized medicine. New biobank facilities are being established globally, focusing on increasing capacity and improving sample management. This expansion supports advancements in genomics, proteomics, and other fields, providing researchers with diverse and high-quality sample repositories for studying diseases, developing treatments, and advancing scientific knowledge.
• Integration of Regenerative Medicine and Biopreservation: The integration of regenerative medicine with biopreservation is transforming the field, particularly in stem cell research and cell therapies. Advances in biopreservation techniques are critical for maintaining the viability of cells and tissues used in regenerative medicine. Innovations in storage methods and cryopreservation protocols enhance the effectiveness of cell-based therapies and support the development of personalized treatments, making biopreservation a key component in the future of regenerative medicine.

These emerging trends significantly reshape the biopreservation market by driving innovation, enhancing sustainability, and expanding capabilities. AI and advanced technologies improve efficiency and reliability, while sustainable practices address environmental concerns. The growth of biobanking facilities and the integration of regenerative medicine further highlight the evolving landscape. Together, these trends set new standards for biopreservation, supporting advances in research, clinical applications, and personalized medicine.



Recent Developments in the Biopreservation Market

The biopreservation market reflects advancements in technology, regulatory frameworks, and market demands. These key developments transform how biological materials are preserved, with significant implications for research, pharmaceuticals, and healthcare. Understanding these developments provides insight into how the market evolves and the factors driving innovation in biopreservation.

• Development of Advanced Cryopreservation Systems: Recent advancements in cryopreservation systems have led to improved preservation of biological materials. New technologies, such as advanced cryoprotectants and more efficient cooling methods, enhance cell viability and reduce damage during thawing. These systems address previous limitations and support the growing demand for high-quality samples in research and clinical applications. The development of these systems is crucial for maintaining the integrity of biological samples and advancing scientific and medical research.
• Growth of Biobank Infrastructure: The expansion of biobank infrastructure is a notable development, with new facilities established worldwide. This growth supports the increasing need for biological samples in research and personalized medicine. Enhanced biobank infrastructure includes improved sample management systems, larger storage capacities, and better data integration. This development facilitates more extensive and diverse research, contributing to advancements in genomics, proteomics, and disease understanding.
• Innovations in Sample Storage Technologies: Innovations in sample storage technologies drive improvements in biopreservation. Advances include the development of energy-efficient storage systems and novel materials that enhance sample stability. These innovations address the challenges of long-term storage and reduce operational costs. Improved storage technologies ensure the integrity of biological samples, supporting their use in research and clinical applications.
• Enhanced Regulatory Frameworks: Enhanced regulatory frameworks shape the biopreservation market by setting higher standards for sample preservation and management. Recent changes in regulations focus on ensuring the quality and safety of biological materials. Compliance with these regulations requires the adoption of advanced preservation techniques and rigorous quality control measures. These regulatory developments support the growth of the biopreservation market by establishing clear guidelines and promoting best practices.
• Increased Focus on Personalized Medicine: The increasing focus on personalized medicine drives advancements in biopreservation. Personalized medicine relies on high-quality biological samples for developing tailored treatments and therapies. Recent developments include improved preservation methods that support the storage and analysis of samples for personalized medicine applications. This focus on personalized medicine expands the role of biopreservation in drug development and patient care.

The biopreservation market enhances preservation techniques, expands infrastructure, and improves regulatory standards. Advances in cryopreservation systems, biobank growth, and storage technologies are crucial for maintaining sample integrity. Enhanced regulations and the focus on personalized medicine further shape the market, driving innovation and supporting the evolution of biopreservation practices. These developments collectively contribute to the advancement of research, pharmaceuticals, and healthcare.

Strategic Growth Opportunities for Biopreservation Market

The biopreservation market is expanding rapidly, driven by technological advancements and growing applications across various sectors. Key growth opportunities are emerging in several applications, reflecting the increasing need for effective preservation methods to ensure the quality and integrity of biological materials. These opportunities span areas such as biobanking, regenerative medicine, pharmaceutical development, diagnostics, and personalized medicine. Understanding these opportunities helps stakeholders align their strategies to capitalize on market growth and innovation.

• Expansion in Biobanking: Biobanking is a significant growth area due to the increasing demand for large-scale, high-quality biological sample repositories. The development of advanced biobank infrastructure and improved sample management technologies enable better collection, storage, and utilization of samples. This expansion supports research in genomics, personalized medicine, and drug discovery by providing a diverse range of well-preserved biological materials. Investment in biobanking infrastructure can enhance research capabilities and facilitate breakthroughs in understanding diseases and developing targeted therapies.
• Advancements in Regenerative Medicine: Regenerative medicine creates substantial growth opportunities in biopreservation. Techniques such as stem cell therapy and tissue engineering require precise preservation methods to maintain cell viability and functionality. Innovations in cryopreservation and storage technologies are critical for supporting these applications. As regenerative medicine advances, the need for reliable biopreservation solutions grows, providing opportunities for companies to develop specialized technologies that cater to the unique requirements of regenerative therapies and enhance their efficacy.
• Growth in Pharmaceutical Development: The pharmaceutical industry’s focus on biopharmaceuticals and complex drugs drives demand for advanced biopreservation methods. The preservation of biologics, such as monoclonal antibodies and vaccines, requires stringent control over storage conditions to ensure product stability and efficacy. Opportunities exist for developing new preservation technologies that improve the shelf life and handling of these sensitive products. As pharmaceutical companies seek to optimize their biopreservation processes, there is potential for significant growth in this sector.
• Innovations in Diagnostic Testing: The increasing complexity and volume of diagnostic testing create opportunities for biopreservation in managing and storing diagnostic samples. Advances in preservation technologies can improve sample quality, accuracy, and reliability in diagnostics. The development of robust biopreservation solutions that can handle diverse types of samples, including blood, tissue, and genetic material, is crucial for supporting the growing diagnostic industry. This creates a niche market for innovative preservation technologies that enhance diagnostic testing capabilities.
• Personalized Medicine: Personalized medicine is expanding rapidly, necessitating advanced biopreservation solutions for tailoring treatments based on individual genetic profiles. The preservation of genomic, proteomic, and other biological data is essential for developing and delivering personalized therapies. Companies have opportunities to create specialized biopreservation systems that support the growing volume of personalized medicine research and applications. By addressing the specific needs of personalized medicine, biopreservation providers can tap into a burgeoning market focused on individualized patient care.

The strategic growth opportunities in biopreservation span biobanking, regenerative medicine, pharmaceutical development, diagnostic testing, and personalized medicine. Each application presents unique opportunities for technological innovation and market expansion. By leveraging these opportunities, stakeholders can enhance their offerings, support advancements in related fields, and contribute to the overall growth of the biopreservation market.

Biopreservation Market Driver and Challenges

The biopreservation market is influenced by a range of drivers and challenges, including technological advancements, economic factors, and regulatory frameworks. Understanding these factors is crucial for navigating the market and identifying growth opportunities. The following analysis explores the key drivers and challenges shaping the biopreservation industry, highlighting their implications and impact.

The factors responsible for driving the biopreservation market include:

• Technological Advancements: Technological innovations in cryopreservation, storage systems, and monitoring technologies are major drivers of growth in the biopreservation market. Advances such as improved cryoprotectants, automated storage solutions, and real-time monitoring systems enhance the efficiency and reliability of preservation methods. These technologies address previous limitations, reduce costs, and support the development of new applications in research, pharmaceuticals, and personalized medicine.
• Increasing Demand for Biobanking: The growing demand for biobanking is a significant driver of the biopreservation market. Biobanks are essential for storing large volumes of biological samples for research and clinical applications. As personalized medicine, genomics, and drug discovery advance, the need for extensive and well-preserved sample repositories increases. Investment in biobank infrastructure and technologies is crucial for meeting this demand and supporting ongoing research and development efforts.
• Growth of Regenerative Medicine: The rise of regenerative medicine, including stem cell therapies and tissue engineering, is driving demand for advanced biopreservation methods. Effective preservation of cells, tissues, and organs is essential for maintaining their viability and functionality. Innovations in cryopreservation and storage techniques cater to the specific needs of regenerative medicine, creating growth opportunities for companies developing specialized preservation solutions.
• Expansion of Pharmaceutical and Biopharmaceutical Markets: The expansion of the pharmaceutical and biopharmaceutical markets, driven by the development of biologics and complex drugs, is fueling demand for biopreservation solutions. Biopharmaceuticals require stringent preservation conditions to ensure stability and efficacy. Advances in preservation technologies that enhance the shelf life and handling of these products are critical for supporting the growth of this sector.
• Increasing Focus on Personalized Medicine: Personalized medicine drives growth in the biopreservation market by requiring advanced preservation methods for genetic, proteomic, and other biological data. The ability to tailor treatments based on individual profiles necessitates precise preservation of biological samples. This focus on personalized medicine creates opportunities for developing biopreservation solutions that support the collection, storage, and analysis of diverse biological data.

Challenges in the biopreservation market are:

• High Costs of Advanced Technologies: The high costs associated with advanced biopreservation technologies can be a significant barrier. Investment in cutting-edge cryopreservation systems, storage facilities, and monitoring equipment requires substantial financial resources. For smaller companies and research institutions, these costs can limit access to the latest technologies and impact their ability to compete in the market.
• Regulatory Compliance: Compliance with stringent regulatory requirements poses a challenge for the biopreservation market. Regulations governing the storage and handling of biological materials are complex and vary by region. Ensuring adherence to these regulations requires continuous updates to preservation practices and investments in quality control measures, which can be resource-intensive for companies operating in multiple jurisdictions.
• Technological Integration and Standardization: Integrating new technologies with existing systems and achieving standardization across the industry can be challenging. The lack of uniform standards for biopreservation practices can lead to inconsistencies in sample quality and preservation outcomes. Developing and adopting standardized protocols and technologies is essential for ensuring reliability and facilitating widespread adoption across the market.

The biopreservation market is shaped by various drivers and challenges. Technological advancements, increasing demand for biobanking, growth in regenerative medicine, expansion of pharmaceutical markets, and the focus on personalized medicine are key drivers propelling market growth. However, high costs, regulatory compliance, and technological integration challenges impact the market's dynamics. Addressing these challenges while leveraging growth drivers will be crucial for stakeholders to navigate the evolving biopreservation landscape effectively.

List of Biopreservation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. through these strategies biopreservation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopreservation companies profiled in this report include-

• Thermo Fisher Scientific
• Merck
• Avantor
• ThermoGenesis
• Bio-Techne Corporation
• BioLife Solutions
• Exact Sciences Corporation
• Worthington Industries
• Chart Industries


Biopreservation by Segment

The study includes a forecast for the global biopreservation by type, biospecimen, application, end use industry, and region.

Biopreservation Market by Type [Analysis by Value from 2019 to 2031]:

• Media
• Equipment


Biopreservation Market by Biospecimen [Analysis by Value from 2019 to 2031]:

• Human Tissue
• Stem Cells
• Organs


Biopreservation Market by Application [Analysis by Value from 2019 to 2031]:

• Therapeutics
• Research
• Clinical Trials


Biopreservation Market by End Use Industry [Analysis by Value from 2019 to 2031]:

• Hospitals
• Biobanks
• Gene Banks
• Others


Biopreservation Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World


Country Wise Outlook for the Biopreservation Market

The biopreservation market is experiencing rapid advancements driven by innovations in technology, regulatory changes, and increasing demand for quality and safety in biopharmaceuticals and healthcare. These developments reshape how biological samples and products are preserved, extending their shelf life and ensuring their integrity. This analysis explores recent developments in the United States, China, Germany, India, and Japan, highlighting key advancements and shifts in each region's biopreservation landscape.

• United States: In the U.S., the biopreservation market is driven by innovations in cryopreservation and the adoption of advanced biopreservation systems. Recent developments include the integration of artificial intelligence for monitoring and optimizing storage conditions. Additionally, the FDA's regulatory support for personalized medicine has spurred growth in biobanking, enhancing research capabilities. Companies are investing in more sophisticated refrigeration technologies and data management systems to ensure the integrity of biological samples, facilitating advances in drug development and personalized therapies.
• China: China is rapidly advancing in biopreservation due to increasing investments in biotechnology and healthcare infrastructure. Recent developments include significant improvements in cryopreservation techniques and the establishment of large-scale biobanks. The government has also implemented supportive policies to foster innovation and collaboration in biopreservation research. Chinese firms focus on developing cost-effective and efficient biopreservation solutions to support the growing demand for biological samples in research and clinical applications, positioning the country as a key player in the global market.
• Germany: Germany is leading in the European biopreservation market with a strong emphasis on technological innovation and sustainability. Recent advancements include the development of new materials and technologies for more efficient cryopreservation and storage. German companies are also exploring novel biopreservation methods that reduce environmental impact, such as eco-friendly cryoprotectants. The country’s robust research infrastructure and collaboration between academia and industry drive advancements in preserving biological materials for pharmaceutical and research purposes.
• India: India is making strides in biopreservation, particularly in the context of biobanking and pharmaceutical research. Recent developments include the expansion of biobank facilities and improvements in cryopreservation technologies tailored to regional needs. Indian companies and research institutions increasingly adopt advanced preservation techniques to enhance the quality and reliability of biological samples. Government initiatives and private investments boost the biopreservation sector, supporting growth in personalized medicine and research capabilities.
• Japan: The Japanese biopreservation market is characterized by its focus on high-tech solutions and integration with cutting-edge research. Recent developments include advancements in cryopreservation technology and the adoption of sophisticated biopreservation systems. Japan is also at the forefront of developing new preservation techniques to support regenerative medicine and cell therapies. The country's strong emphasis on innovation and its supportive regulatory environment drive the evolution of biopreservation practices, enhancing the quality and efficiency of biological sample storage.

Features of the Global Biopreservation Market

Market Size Estimates: Biopreservation market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Biopreservation market size by various segments, such as by type, biospecimen, application, end use industry, and region in terms of value ($B).
Regional Analysis: Biopreservation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, biospecimen, application, end use industry, and regions for the biopreservation market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopreservation market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.


If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the biopreservation market by type (media and equipment), biospecimen (human tissue, stem cells, and organs), application (therapeutics, research, and clinical trials), end use industry (hospitals, biobanks, gene banks, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

ページTOPに戻る

Table of Contents

Table of Contents

1. Executive Summary

2. Global Biopreservation Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Biopreservation Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Biopreservation Market by Type
3.3.1: Media
3.3.2: Equipment
3.4: Global Biopreservation Market by Biospecimen
3.4.1: Human Tissue
3.4.2: Stem Cells
3.4.3: Organs
3.5: Global Biopreservation Market by Application
3.5.1: Therapeutics
3.5.2: Research
3.5.3: Clinical Trials
3.6: Global Biopreservation Market by End Use Industry
3.6.1: Hospitals
3.6.2: Biobanks
3.6.3: Gene Banks
3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Biopreservation Market by Region
4.2: North American Biopreservation Market
4.2.1: North American Biopreservation Market by Type: Media and Equipment
4.2.2: North American Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others
4.3: European Biopreservation Market
4.3.1: European Biopreservation Market by Type: Media and Equipment
4.3.2: European Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others
4.4: APAC Biopreservation Market
4.4.1: APAC Biopreservation Market by Type: Media and Equipment
4.4.2: APAC Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others
4.5: ROW Biopreservation Market
4.5.1: ROW Biopreservation Market by Type: Media and Equipment
4.5.2: ROW Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Biopreservation Market by Type
6.1.2: Growth Opportunities for the Global Biopreservation Market by Biospecimen
6.1.3: Growth Opportunities for the Global Biopreservation Market by Application
6.1.4: Growth Opportunities for the Global Biopreservation Market by End Use Industry
6.1.5: Growth Opportunities for the Global Biopreservation Market by Region
6.2: Emerging Trends in the Global Biopreservation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Biopreservation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopreservation Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Thermo Fisher Scientific
7.2: Merck
7.3: Avantor
7.4: ThermoGenesis
7.5: Bio-Techne Corporation
7.6: BioLife Solutions
7.7: Exact Sciences Corporation
7.8: Worthington Industries
7.9: Chart Industries